Effects of the Bifunctional Sulfoxide MMS350, a Radiation Mitigator, on Hematopoiesis in Long-term Bone Marrow Cultures and on Radioresistance of Marrow Stromal Cell Lines

Documenti analoghi

• Amelioration of Radiation-Induced Pulmonary Fibrosis by a Water-Soluble Bifunctional Sulfoxide Radiation Mitigator (MMS350)
  di: Kalash, Ronny, et al.
  Pubblicazione: (2013)
• Improved Hematopoiesis in GS-Nitroxide (JP4-039)-treated Mouse Long-term Bone Marrow Cultures and Radioresistance of Derived Bone Marrow Stromal Cell Lines
  di: SHINDE, ASHWIN, et al.
  Pubblicazione: (2014)
• Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Ιs Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350
  di: EPPERLY, MICHAEL W, et al.
  Pubblicazione: (2017)
• Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca(−/−)) Mice
  di: Sivananthan, Aranee, et al.
  Pubblicazione: (2018)
• Oxetanyl Sulfoxide MMS-350 Ameliorates Pulmonary Fibrosis In Vitro, In Vivo, and Ex Vivo
  di: Mlakar, Logan, et al.
  Pubblicazione: (2020)